This rapid growth underscores the increasing adoption of GLP-1 receptor agonists for type 2 diabetes management, driven by their efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation
Hazen, M.D., Ph.D., senior author of the study and section head of Preventive Cardiology & Rehabilitation at the Cleveland Clinic
Doglioni C, Ravaglia C, Chilosi M, Rossi G, Dubini A, Pedica F, et al
Prausnitz, M
Conversely, improvements in sleep quality have been shown to enhance metabolic function, stabilize glucose levels, and support healthy weight management
Why Some GLP-1 Medications Cause Less Nausea Once-weekly formulations with gradual dose titration schedules cause less nausea by maintaining stable plasma concentrations and allowing the gut to adapt to delayed gastric emptying